Ross et al., 2018 - Google Patents
Coprocessing of pharmaceutical cocrystals for high quality and enhanced physicochemical stabilityRoss et al., 2018
View PDF- Document ID
- 11164782945816261318
- Author
- Ross S
- Ward A
- Basford P
- McAllister M
- Douroumis D
- Publication year
- Publication venue
- Crystal Growth & Design
External Links
Snippet
Solid state synthesis of high-quality indomethacin–saccharin cocrystals was achieved using hot melt extrusion. The physical and chemical stability of the formed cocrystals was enhanced through coprocessing with inert excipients at the final kneading zone. For the …
- 230000015572 biosynthetic process 0 abstract description 95
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ross et al. | Coprocessing of pharmaceutical cocrystals for high quality and enhanced physicochemical stability | |
Bolla et al. | Crystal engineering of pharmaceutical cocrystals in the discovery and development of improved drugs | |
Li et al. | Mechanochemical synthesis of pharmaceutical cocrystal suspensions via hot melt extrusion: feasibility studies and physicochemical characterization | |
Alhalaweh et al. | Formation of cocrystals from stoichiometric solutions of incongruently saturating systems by spray drying | |
Wu et al. | Transformations between co-amorphous and co-crystal systems and their influence on the formation and physical stability of co-amorphous systems | |
Surov et al. | Pharmaceutical cocrystals of diflunisal and diclofenac with theophylline | |
Ullah et al. | The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance | |
Paluch et al. | Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid | |
Butreddy et al. | Polymer-assisted aripiprazole–adipic acid cocrystals produced by hot melt extrusion techniques | |
Lin et al. | Preparation, characterization, and evaluation of dipfluzine–benzoic acid co-crystals with improved physicochemical properties | |
Paudel et al. | Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films | |
Guns et al. | Comparison between hot-melt extrusion and spray-drying for manufacturing solid dispersions of the graft copolymer of ethylene glycol and vinylalcohol | |
Wang et al. | Preparation, characterization, and formulation development of drug–drug protic ionic liquids of diphenhydramine with ibuprofen and naproxen | |
Pagire et al. | Spherical crystallization of carbamazepine/saccharin co-crystals: Selective agglomeration and purification through surface interactions | |
Zhao et al. | Tuning physicochemical properties of antipsychotic drug aripiprazole with multicomponent crystal strategy based on structure and property relationship | |
Banerjee et al. | Unlocking the potential of drug-drug cocrystals–A comprehensive review | |
Ueda et al. | Mechanism of enhanced nifedipine dissolution by polymer-blended solid dispersion through molecular-level characterization | |
Aitipamula et al. | Crystal engineering of tegafur cocrystals: structural analysis and physicochemical properties | |
Wang et al. | Structural and physicochemical aspects of hydrochlorothiazide co-crystals | |
Zhu et al. | Stable cocrystals and salts of the antineoplastic drug apatinib with improved solubility in aqueous solution | |
Zhu et al. | Polymorphs and hydrates of apatinib mesylate: insight into the crystal structures, properties, and phase transformations | |
Zhang et al. | Microcrystalline cellulose as an effective crystal growth inhibitor for the ternary Ibrutinib formulation | |
Qu et al. | Enhancing stability and formulation capability of fungicides by cocrystallization through a novel multistep slurry conversion process | |
Martena et al. | A new nanospray drying method for the preparation of nicergoline pure nanoparticles | |
Chen et al. | Melt crystallization of celecoxib-carbamazepine cocrystals with the synchronized release of drugs |